Yahoo Finance

Santen and RemeGen sign licence deal for retinal disease injection

The RC28-E intravitreal injection is a dual-target fusion protein aimed at treating retinal diseases. Credit: Sai Thaw Kyar/Shutterstock.com. · Pharmaceutical Technology · Sai Thaw ...
Yahoo Finance

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries

YANTAI, China, Aug. 18, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced ...
Future

DT Swiss RC28 Spline C Mon Chasseral wheelset review

In this brave new world of disc brakes and thru axles it's easy to forget that the majority of us are still riding standard road bikes with conventional rim brakes. DT Swiss has been as big a ...
Mena FN

Remegen And Santen Enter Into Exclusive Licensing Agreement For Ophthalmic Innovative Drug RC28-E In Greater China And Asian Countries

YANTAI, China, Aug. 18, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: SH/09995, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement ...
Pharmabiz

RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries

RemeGen Co., Ltd., a leading Chinese biopharmaceutical company, announced that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. (Santen China), a wholly-owned subsidiary ...